drospirenone has been researched along with Menopause in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (78.57) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Dožić, B; Dožić, I; Srebro, D; Vujović, S; Đogo, A | 1 |
| Carranza-Lira, S | 1 |
| Genazzani, AR; Simoncini, T | 1 |
| Alexandrou, A; Christodoulakos, G; Creatsa, M; Grigoriou, O; Kaparos, G; Karaflou, M; Kouskouni, E; Lambrinoudaki, I; Logothetis, E; Panoulis, C | 1 |
| Gaspard, U; Van den Brûle, F | 1 |
| Ylikorkala, O | 1 |
| Whitehead, M | 1 |
| Stevenson, JC | 1 |
| Shulman, LP | 1 |
| Foidart, JM; Genazzani, AR; Palacios, S | 1 |
| Marazzi, G; Rosano, GM; Vitale, C; Volterrani, M | 1 |
| Archer, DF | 1 |
| Faustmann, T; Foidart, JM | 1 |
| Pérez-López, FR | 1 |
11 review(s) available for drospirenone and Menopause
| Article | Year |
|---|---|
Safety, efficacy and patient acceptability of drospirenone and estradiol in the treatment of menopausal vasomotor symptoms: a review.
Topics: Aged; Androstenes; Blood Pressure; Body Weight; Estradiol; Estrogens; Female; Humans; Lipoproteins; Menopause; Middle Aged; Mineralocorticoid Receptor Antagonists; Patient Acceptance of Health Care; Quality of Life; Treatment Outcome; Vasomotor System | 2009 |
A review of the cardiovascular and breast actions of drospirenone in preclinical studies.
Topics: Androstenes; Animals; Breast; Breast Neoplasms; Cardiovascular Diseases; Cardiovascular System; Estrogen Replacement Therapy; Estrogens; Female; Humans; Menopause; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Progestins; Risk Factors | 2010 |
[Medication of the month. Angeliq: new hormonal therapy of menopause, with antialdosterone and antiandrogenic properties].
Topics: Androstenes; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Mineralocorticoid Receptor Antagonists | 2004 |
Hormone replacement therapy with estradiol and drospirenone: an overview of the clinical data.
Topics: Aged; Androstenes; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endometrial Hyperplasia; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Menopause; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; United Kingdom | 2006 |
A new hormone replacement therapy containing a progestogen with anti-mineralocorticoid activity.
Topics: Aged; Androstenes; Blood Pressure; Blood Pressure Determination; Edema; Female; Hormone Replacement Therapy; Humans; Hypertension; Menopause; Middle Aged; Mineralocorticoids; Progestins; Sensitivity and Specificity; Treatment Outcome; United Kingdom | 2006 |
A review of drospirenone for safety and tolerability and effects on endometrial safety and lipid parameters contrasted with medroxyprogesterone acetate, levonorgestrel, and micronized progesterone.
Topics: Androstenes; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menopause; Progesterone; Women's Health | 2006 |
Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism.
Topics: Androstenes; Blood Pressure; Body Weight; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Randomized Controlled Trials as Topic; Renin-Angiotensin System | 2006 |
Menopause and cardiovascular disease: the evidence.
Topics: Androstenes; Cardiovascular Diseases; Diabetes Mellitus; Estrogen Replacement Therapy; Female; Humans; Hypertension; Menopause; Mineralocorticoid Receptor Antagonists; Risk Factors; Weight Gain | 2007 |
Drospirenone-containing hormone therapy for postmenopausal women. Perspective on current data.
Topics: Androstenes; Bone and Bones; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hypertension; Menopause; Mineralocorticoid Receptor Antagonists | 2007 |
Advances in hormone replacement therapy: weight benefits of drospirenone, a 17alpha-spirolactone-derived progestogen.
Topics: Androstenes; Attitude to Health; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Menopause; Patient Compliance; Progesterone Congeners; Renin-Angiotensin System; Water-Electrolyte Balance; Weight Gain | 2007 |
Clinical experiences with drospirenone: from reproductive to postmenopausal years.
Topics: Androstenes; Contraceptives, Oral, Combined; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Menopause; Mineralocorticoid Receptor Antagonists | 2008 |
1 trial(s) available for drospirenone and Menopause
| Article | Year |
|---|---|
The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women.
Topics: ADAM Proteins; Adult; Androgen Antagonists; Androstenes; CD40 Ligand; Estradiol; Estrogen Replacement Therapy; Female; Health; Humans; Membrane Proteins; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone Congeners | 2010 |
2 other study(ies) available for drospirenone and Menopause
| Article | Year |
|---|---|
Effects of continuous-combined oral drospirenone- estradiol on blood pressure, body weight & lipid profile in early menopausal women.
Topics: Adult; Androstenes; Blood Pressure; Body Weight; Cardiovascular Diseases; Cholesterol; Estradiol; Female; Humans; Hypertension; Lipids; Menopause; Menopause, Premature; Middle Aged; Retrospective Studies | 2021 |
Drospirenone, a progestin with a unique cardiovascular profile, for safe contraception and treatment of menopausal symptoms.
Topics: Androstenes; Bone Remodeling; Contraceptives, Oral; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Mineralocorticoid Receptor Antagonists; Osteoporosis; Premenstrual Syndrome; Progesterone Congeners | 2005 |